Sunday, November 27, 2005

FDA restricts use of Glaxo's Advair
The U.S. Food and Drug Administration had directed that drugmaker GlaxoSmithKline's biggest selling asthmatic drug Advair should be made available to asthmatics only as a last resort.
This isn't good. It is a good product and frequently a life-saver.